Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
12 sept. 2023 08h00 HE
|
Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
Celebrate a New Sesame Street Friend with My Friend Julia: A Sesame Street® Book about Autism by Jennifer Cook
07 sept. 2023 12h08 HE
|
Lerner Publishing Group
Minneapolis, Minnesota, Sept. 07, 2023 (GLOBE NEWSWIRE) -- This September, Lerner Publications™, an imprint of Lerner Publishing Group™, presents My Friend Julia: A Sesame Street® Book about Autism...
Hopebridge Autism Therapy Centers celebrates school-readiness graduations for children across the country
28 août 2023 09h00 HE
|
Hopebridge
Indianapolis, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hundreds of children with autism spectrum disorder (ASD) are prepared to start school this year after graduating from Hopebridge Autism Therapy...
Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment?
15 août 2023 08h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...
Verbal Beginnings to Open New Early Intervention Comprehensive Autism Services Center in Frederick, MD
09 août 2023 09h00 HE
|
Verbal Beginnings
FREDERICK, Md., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Verbal Beginnings, a leading provider of comprehensive Autism services is thrilled to announce the opening of a new location in Frederick, Maryland,...
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
20 juil. 2023 09h07 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, July 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
14 juil. 2023 07h55 HE
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Joshin Delivers Pioneering Inclusive Support Program to Tyson Foods
28 juin 2023 09h00 HE
|
Joshin
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) -- Joshin, a company that provides comprehensive solutions for disability and neurodivergence support in the workplace, today announced it is expanding...
PaxMedica CEO Interviewed by The BRAIN Foundation
20 juin 2023 08h30 HE
|
PaxMedica, Inc.
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on...
PaxMedica Completes HAT-301 Registrational Trial for PAX-101
01 juin 2023 08h00 HE
|
PaxMedica, Inc.
HAT-301 is the Pivotal Efficacy Study to Support Upcoming NDA Filing Top Line Results Planned for Release in July 2023 TARRYTOWN, NY, June 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...